0000950123-17-000924.txt : 20170207 0000950123-17-000924.hdr.sgml : 20170207 20170207060253 ACCESSION NUMBER: 0000950123-17-000924 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170207 DATE AS OF CHANGE: 20170207 EFFECTIVENESS DATE: 20170207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SV Life Sciences Advisers, LLC CENTRAL INDEX KEY: 0001587143 IRS NUMBER: 861154144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16271 FILM NUMBER: 17577126 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001587143 XXXXXXXX 12-31-2016 12-31-2016 SV Life Sciences Advisers, LLC

ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108

13F HOLDINGS REPORT 028-16271 Y The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Life Sciences Advisers, LLC, a Delaware limited liability company ("Advisers"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and International Life Sciences Fund III (LP 1), L.P. ("ILSF LP1"), International Life Sciences Fund III Co- Investment, L.P. ("ILSF Co-Invest"), and International Life Sciences Fund III Strategic Partners, L.P. ("ILSF Strategic" and together with ILSF LP1 and ILSF Co-Invest, the "Fund III Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund III Entities and the Fund V Entities together, the "Funds"), directly own certain security positions reported by Advisers, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. Certain of the security positions reported by Advisers are also being reported by SVLS IV GP and SVLSF IV, LLC. Each of SVLS IV GP, SVLSF IV, LLC and Advisers may be deemed to share voting power and control over the shares held by the Fund IV Entities. Advisers may be deemed to share voting power and control over the shares held by the Fund III Entities and the Fund V Entities. Each of SVLS IV GP, SVLSF IV, LLC and Advisers disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein. Denise W. Marks (617) 367-8100 /s/ Denise W. Marks Boston MA 02-07-2017 2 6 118762 false 1 028-16272 SVLSF IV, LLC 2 028-16273 SV Life Sciences Fund IV (GP), L.P. INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F TRANSENTERIX INC COM NEW 89366M201 9811 7546692 SH OTR 1,2 0 7546692 0 OCULAR THERAPEUTIX INC COM 67576A100 13436 1605207 SH OTR 1,2 0 1605207 0 ENTELLUS MED INC COM 29363K105 66198 3489533 SH OTR 1,2 0 3489533 0 CATABASIS PHARMACEUTICALS IN COM 14875P107 10315 2857667 SH OTR 0 2857667 0 LOMBARD MED INC COM G55598109 765 1275779 SH OTR 1,2 0 1275779 0 KALVISTA PHARMACEUTICALS INC COM 483497103 18237 2579490 SH OTR 1,2 0 2579490 0